Remote versus early corticosteroid wean outcomes in heart transplant recipients in the contemporary era

Purpose The risks and benefits of remote corticosteroid weaning in heart transplant recipients more than 2 years post‐transplant are unknown. We compared outcomes in patients undergoing early and remote steroid weaning after heart transplantation. Methods We performed a retrospective study (range 09...

Full description

Saved in:
Bibliographic Details
Published in:Clinical transplantation 2021-08, Vol.35 (8), p.e14382-n/a
Main Authors: Salgado, Benjamin C., Fida, Nadia, Krisl, Jill, Berens, Pauline M., Graviss, Edward. A., Nguyen, Duc T., Hussain, Imad, Kim, Ju H., Suarez, Erik, Trachtenberg, Barry, Torre‐Amione, Guillermo, Bhimaraj, Arvind, Guha, Ashrith
Format: Article
Language:English
Subjects:
heart transplantation
immunosuppression
steroids
weaning
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose The risks and benefits of remote corticosteroid weaning in heart transplant recipients more than 2 years post‐transplant are unknown. We compared outcomes in patients undergoing early and remote steroid weaning after heart transplantation. Methods We performed a retrospective study (range 09, 1991–04, 2017). Primary outcomes included short‐term and long‐term mortality, allograft dysfunction, and burden of rejection. Secondary outcomes included impact on hemoglobin A1c, lipid panel, bone scan T‐score, and body mass index. Results 63 patients underwent corticosteroid weaning between 2012 and 2017. Outcomes of patients weaned early (n = 34; median time from transplant = 1.1 years) were compared with those weaned late (n = 29; median time from transplant = 4.4 years). 52 (82.5%) patients were successfully weaned off corticosteroids. No statistically significant difference in outcomes was found between the early and late weaning groups (p = .20). There were no differences in allograft function (p‐value = .16), incidence of rejection (p = .46), or mortality (p = .15). Improvement in metabolic profile was seen in both groups but was not statistically significant. Conclusions In heart transplant recipients, remote vs early weaning of corticosteroids is not associated with significant differences in graft function or the incidence of rejection after 1‐year follow‐up. Moreover, there were no significant differences in survival up to 3 years between the two groups.
ISSN:0902-0063
1399-0012
DOI:10.1111/ctr.14382